Organization Overview
Alternative names
cetuximab (erbitux) (2 trials)
cisplatin (platinol) (6 trials)
cyclophosphamide (cytoxan) (5 trials)
acetylsalicylic acid (aspirin) (1 trial)
aflibercept (zaltrap) (1 trial)
atezolizumab (Tecentriq) (5 trials)
avelumab (bavencio) (2 trials)
azacitidine (vidaza) (1 trial)
belimumab (benlysta) (1 trial)
bevacizumab (avastin) (2 trials)
binimetinib (mektovi) (2 trials)
bortezomib (velcade) (2 trials)
carboplatin (paraplatin) (4 trials)
cobimetinib (cotellic) (2 trials)
dabrafenib (tafinlar) (2 trials)
darolutamide (Nubeqa) (1 trial)
docetaxel (taxotere) (2 trials)
eltrombopag (promacta) (2 trials)
emapalumab-lzsg (gamifant) (1 trial)
encorafenib (braftovi) (2 trials)
fludarabine (fludara) (1 trial)
lenalidomide (revlimid) (5 trials)
lutetium (177Lu) vipivotide tetraxetan (Pluvicto) (7 trials)
obinutuzumab (gazyva) (2 trials)
osimertinib (tagrisso) (1 trial)
oxaliplatin (eloxatin) (2 trials)
palbociclib (ibrance) (3 trials)
panobinostat (farydak) (1 trial)
pembrolizumab (keytruda) (12 trials)
Bone Neoplasms (Phase 1)
Breast Neoplasms (Phase 4)
Carcinoma (Phase 3)
Carcinoma, Adenoid Cystic (Phase 1)
Carcinoma, Merkel Cell (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Squamous Cell (Phase 3)
Carcinosarcoma (Phase 2)
Colonic Neoplasms (Phase 3)
Colorectal Neoplasms (Phase 2)
Esophageal Neoplasms (Phase 2)
Fallopian Tube Neoplasms (Phase 2)
Fatigue (Phase 3)
Gastrointestinal Stromal Tumors (Phase 3)
Head and Neck Neoplasms (Phase 2)
Hodgkin Disease (Phase 2)
Infertility (Phase 3)
Leukemia (Phase 2)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Lung Neoplasms (Phase 4)
Lymphoma (Phase 3)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Lymphoma, Follicular (Phase 3)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 3)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Cutaneous (Phase 1)
Lymphoma, T-Cell, Peripheral (Phase 2)
Melanoma (Phase 2)
Mixed Tumor, Mullerian (Phase 2)
Multiple Myeloma (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Myeloproliferative Disorders (Phase 2)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Ovarian Neoplasms (Phase 2)
Parasomnias (Phase 3)
Polycythemia (Phase 2)
Polycythemia Vera (Phase 2)
Preleukemia (Phase 2)
Primary Myelofibrosis (Phase 2)
Prostatic Neoplasms (Phase 3)
Rectal Neoplasms (Phase 2)
Recurrence (Phase 2)
Sarcoma (Phase 2)
Sleep Wake Disorders (Phase 3)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stomach Neoplasms (Phase 3)
Syndrome (Phase 2)
Thrombocythemia, Essential (Phase 2)
Thrombocytopenia (Phase 2)
Thrombocytosis (Phase 2)
Triple Negative Breast Neoplasms (Phase 2)
Urinary Bladder Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 1)
Virus Diseases (Phase 3)
Waldenstrom Macroglobulinemia (Phase 2)